Mammalian fatty acid synthase: a commonly used viral host dependency factor and a putative target for host-targeted broad-spectrum antiviral therapeutic development.

Publication date: Jun 25, 2025

Viruses regulate host processes to create cellular environments favorable to viral replication. At least 27 viruses that infect humans require host fatty acid synthase (FASN)-dependent de novo fatty acid biosynthesis, including viruses from the Coronaviridae, Flaviviridae, Herpesviridae, Picornaviridae, Retroviridae, and Togaviridae families. How could FASN activity and subsequent de novo fatty acid production impact viral replication? FASN activity produces the fatty acid palmitate, which can be further metabolized into fatty acids that are used to form lipid droplets that can be used during viral assembly and budding, for beta-oxidation to generate ATP, and to create fatty acyl groups used for post-translational protein modification to change the subcellular localization of viral or host proteins. In this minireview, we outline the function of FASN, review the mechanisms linking virus replication and fatty acid biosynthesis, and consider the potential of FASN as a target for broad-spectrum antiviral drug development.

Open Access PDF

Concepts Keywords
Atp antiviral pharmacology
Biosynthesis coronavirus
Budding FASN
Herpesviridae flavivirus
Viral virus-host interactions

Semantics

Type Source Name
disease IDO host
pathway KEGG Viral replication
pathway KEGG Fatty acid biosynthesis
disease IDO production
drug DRUGBANK Palmitic Acid
pathway REACTOME Fatty acids
pathway REACTOME Budding
drug DRUGBANK ATP
pathway REACTOME Post-translational protein modification
disease IDO replication

Original Article

(Visited 2 times, 1 visits today)